Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Oct-24 5:36 PM View:  | Collins Cynthia Director | Maxcyte, Inc. (MXCT) | 14-Oct-24 | Grant | 51,679 | -- | -- | 100% 0 to 51.68K | |
| 02-Oct-24 5:03 PM View: | Erck Stanley C Director | Maxcyte, Inc. (MXCT) | 02-Oct-24 | Planned Option Sale | 21,607 | $3.71 | $80,162.00 | (7%) 290.73K to 269.12K | |
| 02-Oct-24 5:03 PM View: | Erck Stanley C Director | Maxcyte, Inc. (MXCT) | 02-Oct-24 | Option Exercise | 21,607 | $0.04 | $864.28 | 8% 269.12K to 290.73K | |
| 02-Oct-24 5:03 PM View: | Erck Stanley C Director | Maxcyte, Inc. (MXCT) | 01-Oct-24 | Planned Option Sale | 26,082 | $3.78 | $98,590.00 | (9%) 295.2K to 269.12K | |
| 02-Oct-24 5:03 PM View: | Erck Stanley C Director | Maxcyte, Inc. (MXCT) | 01-Oct-24 | Option Exercise | 26,082 | $0.04 | $1,043.28 | 10% 269.12K to 295.2K | |
| 30-Sep-24 4:15 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Sep-24 | Planned Option Sale | 3,000 | $3.82 | $11,460.00 | (2%) 144.95K to 141.95K | |
| 30-Sep-24 4:15 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Sep-24 | Option Exercise | 3,000 | $2.93 | $8,778.00 | 2% 141.95K to 144.95K | |
| 18-Sep-24 4:34 PM View: | Soleymannezhad Ali Chief Commercial Officer | Maxcyte, Inc. (MXCT) | 16-Sep-24 | Grant | 10,400 | -- | -- | 67% 15.63K to 26.02K | |
| 28-Aug-24 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Aug-24 | Option Exercise | 3,000 | $2.93 | $8,778.00 | 2% 141.95K to 144.95K | |
| 28-Aug-24 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Aug-24 | Planned Option Sale | 3,000 | $4.28 | $12,840.00 | (2%) 144.95K to 141.95K | |
| 05-Aug-24 6:57 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 02-Aug-24 | Option Exercise | 17,857 | $1.64 | $29,303.30 | 71% 25.0K to 42.86K | |
| 05-Aug-24 6:57 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 02-Aug-24 | Planned Option Sale | 17,857 | $4.36 | $77,874.40 | (42%) 42.86K to 25.0K | |
| 05-Aug-24 6:57 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 01-Aug-24 | Planned Option Sale | 15,476 | $4.54 | $70,261.00 | (38%) 40.48K to 25.0K | |
| 05-Aug-24 6:57 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 01-Aug-24 | Option Exercise | 15,476 | $1.64 | $25,396.10 | 62% 25.0K to 40.48K | |
| 30-Jul-24 4:39 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jul-24 | Option Exercise | 3,000 | $2.93 | $8,778.00 | 2% 141.95K to 144.95K | |
| 30-Jul-24 4:39 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jul-24 | Planned Option Sale | 3,000 | $4.75 | $14,238.00 | (2%) 144.95K to 141.95K | |
| 10-Jul-24 4:15 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 09-Jul-24 | Planned Option Sale | 13,531 | $4.03 | $54,584.10 | (35%) 38.53K to 25.0K | |
| 10-Jul-24 4:15 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 09-Jul-24 | Option Exercise | 13,531 | $1.64 | $22,204.40 | 54% 25.0K to 38.53K | |
| 10-Jul-24 4:15 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 08-Jul-24 | Option Exercise | 19,802 | $1.64 | $32,495.10 | 79% 25.0K to 44.8K | |
| 10-Jul-24 4:15 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 08-Jul-24 | Planned Option Sale | 19,802 | $4.03 | $79,782.30 | (44%) 44.8K to 25.0K | |
| 24-Jun-24 4:17 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 20-Jun-24 | Planned Option Sale | 33,333 | $4.09 | $136,465.00 | (57%) 58.33K to 25.0K | |
| 24-Jun-24 4:17 PM View: | Ross Thomas M. EVP, GLOBAL SALES | Maxcyte, Inc. (MXCT) | 20-Jun-24 | Option Exercise | 33,333 | $1.64 | $54,699.50 | 133% 25.0K to 58.33K | |
| 13-Jun-24 5:37 PM View: | Erck Stanley C Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 9% 247.75K to 269.12K | |
| 13-Jun-24 5:39 PM View: | Douglas Richard Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 21% 100.0K to 121.37K | |
| 13-Jun-24 5:32 PM View: | Al-Wakeel Yasir B. Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 100% 0 to 21.37K | |
| 13-Jun-24 5:30 PM View: | Balthrop Patrick J Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 100% 0 to 21.37K | |
| 13-Jun-24 5:41 PM View: | Mandell Art Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 6% 374.48K to 395.85K | |
| 13-Jun-24 5:27 PM View: | Brooke William W Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 42% 50.3K to 71.67K | |
| 13-Jun-24 5:38 PM View: | Hemrajani Rekha Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 100% 0 to 21.37K | |
| 13-Jun-24 5:31 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 18% 120.58K to 141.95K | |
| 10-Jun-24 5:55 PM View: | Masoud Maher President and CEO Director | Maxcyte, Inc. (MXCT) | 10-Jun-24 | Purchase | 70,443 | $4.90 | $345,241.00 | 238% 29.56K to 100.0K | |
| 10-Jun-24 5:55 PM View: | Masoud Maher President and CEO Director | Maxcyte, Inc. (MXCT) | 07-Jun-24 | Purchase | 29,557 | $4.87 | $143,824.00 | 100% 0 to 29.56K | |
| 28-Mar-24 4:31 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Mar-24 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 28-Mar-24 4:31 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Mar-24 | Planned Option Sale | 5,000 | $4.41 | $22,025.00 | (4%) 125.58K to 120.58K | |
| 19-Mar-24 6:21 PM View: | Ross Thomas M. EVP, Global Sales & Marketing | Maxcyte, Inc. (MXCT) | 15-Mar-24 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 19-Mar-24 6:18 PM View: | Swirsky Douglas J Chief Financial Officer | Maxcyte, Inc. (MXCT) | 15-Mar-24 | Grant | 81,250 | -- | -- | 100% 0 to 81.25K | |
| 19-Mar-24 6:20 PM View: | Sandoval David I. General Counsel | Maxcyte, Inc. (MXCT) | 15-Mar-24 | Grant | 3,913 | -- | -- | 9% 42.0K to 45.91K | |
| 28-Feb-24 10:00 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Feb-24 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 28-Feb-24 10:00 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Feb-24 | Planned Option Sale | 5,000 | $4.60 | $23,005.00 | (4%) 125.58K to 120.58K | |
| 30-Jan-24 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jan-24 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 30-Jan-24 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jan-24 | Planned Option Sale | 5,000 | $5.12 | $25,585.00 | (4%) 125.58K to 120.58K | |
| 28-Dec-23 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Dec-23 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 28-Dec-23 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Dec-23 | Planned Option Sale | 5,000 | $4.53 | $22,650.00 | (4%) 125.58K to 120.58K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 05-Dec-23 | Option Exercise | 99,442 | $0.04 | $3,977.68 | 30% 333.2K to 432.64K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 05-Dec-23 | Planned Option Sale | 99,442 | $5.17 | $514,115.00 | (23%) 432.64K to 333.2K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 04-Dec-23 | Planned Option Sale | 25,008 | $5.01 | $125,290.00 | (7%) 358.2K to 333.2K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 04-Dec-23 | Option Exercise | 25,008 | $0.04 | $1,000.32 | 8% 333.2K to 358.2K | |
| 01-Dec-23 5:14 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 01-Dec-23 | Option Exercise | 20,200 | $0.04 | $808.00 | 6% 333.2K to 353.4K | |
| 01-Dec-23 5:14 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 01-Dec-23 | Planned Option Sale | 20,200 | $5.00 | $101,000.00 | (6%) 353.4K to 333.2K | |
| 01-Dec-23 5:14 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 29-Nov-23 | Option Exercise | 5,350 | $0.04 | $214.00 | 2% 333.2K to 338.55K |
